201 related articles for article (PubMed ID: 7499850)
1. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
[TBL] [Abstract][Full Text] [Related]
2. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
Auger I; Sebbag M; Vincent C; Balandraud N; Guis S; Nogueira L; Svensson B; Cantagrel A; Serre G; Roudier J
Arthritis Rheum; 2005 Nov; 52(11):3424-32. PubMed ID: 16255019
[TBL] [Abstract][Full Text] [Related]
3. Possible association of non-binding of HSP70 to HLA-DRB1 peptide sequences and protection from rheumatoid arthritis.
Maier JT; Haug M; Föll JL; Beck H; Kalbacher H; Rammensee HG; Dannecker GE
Immunogenetics; 2002 May; 54(2):67-73. PubMed ID: 12037598
[TBL] [Abstract][Full Text] [Related]
4. Specific overexpression of rheumatoid arthritis-associated HLA-DR alleles and presentation of low-affinity peptides.
Kerlan-Candon S; Louis-Plence P; Wiedemann A; Combe B; Clot J; Eliaou JF; Pinet V
Arthritis Rheum; 2001 Jun; 44(6):1281-92. PubMed ID: 11407687
[TBL] [Abstract][Full Text] [Related]
5. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition.
Zanelli E; Krco CJ; David CS
J Immunol; 1997 Apr; 158(7):3545-51. PubMed ID: 9120317
[TBL] [Abstract][Full Text] [Related]
6. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
[TBL] [Abstract][Full Text] [Related]
7. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
[TBL] [Abstract][Full Text] [Related]
8. Role of hydrophobic amino acids at position 74 of DRB1 chain in rheumatoid arthritis.
Cerná M; Havelka S; Ivasková E
Arch Immunol Ther Exp (Warsz); 1995; 43(2):139-44. PubMed ID: 8744729
[TBL] [Abstract][Full Text] [Related]
9. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
[TBL] [Abstract][Full Text] [Related]
10. Discordant expression of HLA class II-associated co-chaperones and HLA-DRB alleles in cultured fibroblast-like synoviocytes.
Spurrell DR; Oldford SA; Frost T; Larsen B; Codner D; Edgecombe A; Drover S
Hum Immunol; 2004 Dec; 65(12):1516-29. PubMed ID: 15603880
[TBL] [Abstract][Full Text] [Related]
11. Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules.
Fridkis-Hareli M; Neveu JM; Robinson RA; Lane WS; Gauthier L; Wucherpfennig KW; Sela M; Strominger JL
J Immunol; 1999 Apr; 162(8):4697-704. PubMed ID: 10202010
[TBL] [Abstract][Full Text] [Related]
12. Identification of HLA-DRB1-bound self-peptides following measles virus infection.
Ovsyannikova IG; Johnson KL; Naylor S; Poland GA
J Immunol Methods; 2005 Feb; 297(1-2):153-67. PubMed ID: 15777939
[TBL] [Abstract][Full Text] [Related]
13. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
Monji T; McCormack AL; Yates JR; Pious D
J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705
[TBL] [Abstract][Full Text] [Related]
14. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
Davenport MP; Quinn CL; Chicz RM; Green BN; Willis AC; Lane WS; Bell JI; Hill AV
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6567-71. PubMed ID: 7604034
[TBL] [Abstract][Full Text] [Related]
15. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
16. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
Kropshofer H; Max H; Halder T; Kalbus M; Muller CA; Kalbacher H
J Immunol; 1993 Nov; 151(9):4732-42. PubMed ID: 8409432
[TBL] [Abstract][Full Text] [Related]
17. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
Yuen MH; Macklin KD; Conti-Fine BM
J Autoimmun; 1996 Feb; 9(1):67-77. PubMed ID: 8845056
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells.
Hansen BE; Andersson EC; Madsen LS; Engberg J; Søndergaard L; Svejgaard A; Fugger L
Tissue Antigens; 1998 Feb; 51(2):119-28. PubMed ID: 9510368
[TBL] [Abstract][Full Text] [Related]
19. HLA-DP2: self peptide sequences and binding properties.
Chicz RM; Graziano DF; Trucco M; Strominger JL; Gorga JC
J Immunol; 1997 Nov; 159(10):4935-42. PubMed ID: 9366419
[TBL] [Abstract][Full Text] [Related]
20. HLA-DRB1 alleles and shared amino acid sequences in disease susceptibility and severity in patients from eastern France with rheumatoid arthritis.
Toussirot E; Auge B; Tiberghien P; Chabod J; Cedoz JP; Wendling D
J Rheumatol; 1999 Jul; 26(7):1446-51. PubMed ID: 10405928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
